Motol University Hospital is a large teaching hospital in the Motol area of Prague. It is the largest medical facility in the Czech Republic and one of the largest in Europe.

There are 2,410 beds in University Hospital Motol; Department of Urology.

During the past decade, University Hospital Motol; Department of Urology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University Hospital Motol; Department of Urology" are "Carcinoma, Transitional Cell" (1 trials) and "Urothelial Carcinoma" (1 trials). Many other conditions were trialed in "University Hospital Motol; Department of Urology" in a lesser frequency.

Most popular intervention types in "University Hospital Motol; Department of Urology" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials), "Gemcitabine" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Motol; Department of Urology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University Hospital Motol; Department of Urology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University Hospital Motol; Department of Urology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Motol; Department of Urology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".